Cingulate Inc

-0.01 (-1.53%)
6:41:27 PM EDT: $0.70 -0.01 (-1.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Cingulate Inc Stock, NASDAQ:CING

1901 West 47th Place, Kansas City, Kansas 66205
United States of America
Phone: +1.913.942.2300
Number of Employees: 15


Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in 2013 and is headquartered in Kansas City, KS.